Tyrosine Supplements and MAO Inhibitors Can Trigger a Hypertensive Crisis
Tyrosine is converted into adrenaline and dopamine. MAO inhibitors block their breakdown. The pressure surge that results can be dangerous and rapid.
Tyrosine is an amino acid supplement taken for cognitive performance, stress resilience, and focus. MAO inhibitors are a class of antidepressants with a well-documented sensitivity to dietary amines. The combination produces a reaction serious enough to be classified among the most hazardous drug-supplement interactions in clinical practice.
The biochemistry
Tyrosine is the direct precursor to catecholamines: dopamine, noradrenaline (norepinephrine), and adrenaline (epinephrine). These are the neurotransmitters and hormones involved in the stress response, attention, and blood pressure regulation.
Once catecholamines are released and have acted on their receptors, they are broken down by an enzyme called monoamine oxidase (MAO). This enzyme acts as a cleanup mechanism, preventing catecholamine levels from climbing unchecked.
Monoamine oxidase inhibitors (MAOIs), used as antidepressants, block this enzyme. Without MAO activity, catecholamines accumulate after release rather than being rapidly degraded.
What happens when tyrosine is added
If a person on an MAOI takes tyrosine as a supplement, they are feeding substrate into the catecholamine production chain at the same time that the breakdown pathway is blocked. The result is that dopamine, noradrenaline, and potentially adrenaline build up to levels far beyond what the body would normally allow.
The cardiovascular consequence is a hypertensive crisis: a rapid, severe spike in blood pressure. Hypertensive crisis can cause stroke, cardiac events, aortic dissection, and death. It is a medical emergency.
This reaction is well-understood because a similar mechanism underlies the “tyramine reaction” in patients on MAOIs who eat aged cheeses, cured meats, or fermented foods — which are high in tyramine, another dietary amine that is also a catecholamine precursor.
Why tyrosine supplements are a particular risk
Supplemental tyrosine delivers a concentrated dose of catecholamine precursor in a way that dietary protein does not, because protein-bound amino acids are released more slowly. A 500mg or 1,000mg tyrosine capsule represents a significant load.
MAOIs in current clinical use include phenelzine, tranylcypromine, and selegiline. Some people also take herbal or natural products that have mild MAO-inhibiting properties, such as certain Ayurvedic preparations, though the clinical significance of those interactions is less certain.
A clear contraindication
Anyone taking a pharmaceutical MAOI should not take tyrosine supplements. This is among the clearest and most serious contraindications in the supplement literature, with a well-defined mechanism and documented serious outcomes.
Reference
- Examine.com. "Tyrosine: Drug Interactions." examine.com
